4.7 Article

Weight loss as treatment for knee osteoarthritis symptoms in obese patients: 1-year results from a randomised controlled trial

期刊

ANNALS OF THE RHEUMATIC DISEASES
卷 70, 期 10, 页码 1798-1803

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/ard.2010.142018

关键词

-

资金

  1. Oak Foundation
  2. Frederiksberg Hospital
  3. Copenhagen Hospital
  4. Danish Rheumatism Association
  5. Horslev Fonden
  6. Bjarne Jensen Fond
  7. Dansk Droge A/S

向作者/读者索取更多资源

Objective To evaluate 1-year symptomatic improvement in obese patients with knee osteoarthritis (OA) on an intensive low-energy diet (LED) maintained by frequent consultations with a dietician compared to minimal attention. Methods The LED programme consisted of group therapy with dietary consultations and two periods of a low-calorie diet of 810 kcal/day during weeks 0-8 and weeks 32-36. The control group only received dietary instruction and attention for 2 h at baseline, and at weeks 8, 32, 36 and 52. The primary end point (total Western Ontario and McMaster Universities (WOMAC) index) was assessed as the mean group difference during and after 1 year. Results The study population consisted of 89 patients, 89% women, average age 63 years. After 1 year, mean weight loss in the LED group was - 10.9 kg (11%) versus - 3.6 kg (4%) in the control group (p<0.0001). There was no difference between the groups in total WOMAC index (p=0.11), although both groups improved. However, the LED intervention resulted in less WOMAC pain (7.7 mm), with a group mean difference of 7.2 mm (95% CI 1.0 to 13.4, p=0.022). After one year 14 (32.8%) responded to LED versus 7 (15.6%) to control, with an absolute benefit of 16.3% (-1.1& to 33.6%, p=0.066). Conclusion Continuous reinforcement of a weight loss programme can be successful over a year in obese knee OA patients. Weight loss was statistically reflected only by a reduction in pain. However, the overall clinical benefits of the intervention on health should lead to a strong recommendation of weight loss in this group of patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rheumatology

Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group

Jose B. Nergon, Maria A. Lopez-Olivo, Loreto Carmona, Robin Christensen, Francesca Ingegnoli, Natalia Zamora, Jorge I. Gamez-Nava, Laura Gonzalez-Lopez, Vibeke Strand, Niti Goel, Tiffany Westrich-Robertson, Maria E. Suarez-Almazor

Summary: This study aimed to identify patient-centered domains with long-term relevance to people with rheumatoid arthritis (RA). Semi-structured individual cognitive interviews were conducted with RA patients from five different countries. Six main themes were identified, including living with symptoms and functional limitations, lack of participation, partner and family issues, risk of damage to vital organs, coping strategies, and healthcare concerns. These domains are seldom measured in longitudinal registries and should be considered in patient-centered longitudinal studies.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2023)

Article Rheumatology

The effect of group-based cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis: a randomized controlled trial

Kristine M. Latocha, Katrine B. Loppenthin, Mikkel Ostergaard, Poul J. Jennum, Merete L. Hetland, Henrik Rogind, Tine Lundbak, Julie Midtgaard, Robin Christensen, Bente A. Esbensen

Summary: The objective of the study was to compare the effects of cognitive behavioural therapy for insomnia (CBT-I) to usual care on sleep efficiency. The study found that CBT-I did not significantly improve sleep efficiency measured by polysomnography (PSG). However, CBT-I showed significant improvement in patient-reported sleep and RA-related outcomes.

RHEUMATOLOGY (2023)

Article Nutrition & Dietetics

The New Nordic Renal Diet Induces a Pronounced Reduction of Urine Acid Excretion and Uremic Toxins in Chronic Kidney Disease Patients (Stage 3 and 4)

Nikita Misella Hansen, Peder Berg, Marianne Rix, Manan Pareek, Jens Leipziger, Anne -Lise Kamper, Arne Astrup, Mads Vaarby Sorensen, Louise Salomo

Summary: The objective of this study was to evaluate the effects of the New Nordic Renal Diet (NNRD) on metabolic acidosis and uremic toxins in patients with moderate CKD. The results showed that one week of NNRD effectively improved metabolic acidosis and reduced urinary excretion of uric acid and uremic toxins. These results provide encouragement for further investigations on the long-term renal protection effects of NNRD in patients with CKD.

JOURNAL OF RENAL NUTRITION (2023)

Article Orthopedics

Who are likely to benefit from the Good Life with osteoArthritis in Denmark (GLAD) exercise and education program? An effect modifier analysis of a randomised controlled trial

M. Henriksen, S. M. Nielsen, R. Christensen, L. E. Kristensen, H. Bliddal, C. Bartholdy, M. Boesen, K. Ellegaard, D. J. Hunter, R. Altman, E. Bandak

Summary: This study aimed to identify contextual factors that modify the treatment effect of the GLAD exercise and education programme compared to open-label placebo on knee pain in individuals with knee OA. The results suggest that patients who take analgesics or report constant knee pain seem to benefit more from the GLAD programme compared to OLP in terms of knee pain.

OSTEOARTHRITIS AND CARTILAGE (2023)

Article Orthopedics

Exercise and education vs intra-articular saline for knee osteoarthritis: a 1-year follow-up of a randomized trial

M. Henriksen, R. Christensen, L. E. Kristensen, H. Bliddal, C. Bartholdy, M. Boesen, K. Ellegaard, J. Guldberg-Moller, D. J. Hunter, R. Altman, E. Bandak

Summary: This study aimed to assess the long-term effect of the GLAD exercise and education program compared to open-label placebo on core outcomes in individuals with knee osteoarthritis. The study found that both GLAD and placebo had minor benefits in improving pain, but there was no significant difference between the two.

OSTEOARTHRITIS AND CARTILAGE (2023)

Article Rheumatology

Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial

L. Uhrenholt, R. Christensen, L. Dreyer, E-M Hauge, A. Schlemmer, A. G. Loft, M. N. B. Rasch, H. C. Horn, K. H. Gade, R. D. Ostgard, P. C. Taylor, K. Duch, S. Kristensen

Summary: This study aimed to evaluate whether disease activity-guided tapering of biologics enables a significant dose reduction while maintaining equivalent disease activity. The results showed that disease activity-guided tapering of biologics allowed one-third of the patients to achieve a reduction of 50% or more, while disease activity remained equivalent between the tapering and control groups. Although flare rates were higher in the tapering group, they could be managed with rescue therapy.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2023)

Article Rheumatology

Prevalence of survey-based criteria for fibromyalgia and impact on hospital burden: a 7 year follow-up study from an outpatient clinic

P. R. Lage-Hansen, S. Chrysidis, K. Amris, S. Fredslund-Andersen, R. Christensen, T. Ellingsen

Summary: This study evaluated the prevalence of survey-based fibromyalgia (FM) criteria among newly referred patients in a rheumatic outpatient clinic, and compared the use of healthcare services between survey-based FM and non-FM cases. The study found that FM cases were more likely to be women and received more medications and public economic support. FM cases also had a higher number of hospital courses and had undergone more invasive procedures compared to non-FM cases. Consultations with various specialists were also more frequent for FM cases.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2023)

Letter Rheumatology

Optimizing the reporting and conduct of systematic literature reviews and meta-analyses

Zhivana Boyadzhieva, Sabrina Mai Nielsen, Frank Buttgereit, Robin Christensen, Andriko Palmowski

ZEITSCHRIFT FUR RHEUMATOLOGIE (2023)

Editorial Material Orthopedics

Guidelines for a structured manuscript: Statistical methods and reporting in biomedical research journals

Robin Christensen, Jonas Ranstam, Soren Overgaard, Philippe Wagner

ACTA ORTHOPAEDICA (2023)

Article Cardiac & Cardiovascular Systems

The left atrial appendage closure by surgery-2 (LAACS-2) trial protocol rationale and design of a randomized multicenter trial investigating if left atrial appendage closure prevents stroke in patients undergoing open-heart surgery irrespective of preoperative atrial fibrillation status and stroke risk

Christoffer Laessoe Madsen, Jesper Park-Hansen, Akhmadjon Irmukhamedov, Christian Lildal Carranza, Sulman Rafiq, Rafael Rodriguez-Lecoq, Neiser Palmer-Camino, Ivy Susanne Modrau, Emma C. Hansson, Anders Jeppsson, Rakin Hadad, Angel Moya-Mitjans, Anders Moller Greve, Robin Christensen, Helle Gervig Carstensen, Nis Baun Host, Ulrik Dixen, Christian Torp-Pedersen, Lars Kober, Ismail Gogenur, Thomas Clement Truelsen, Christina Kruuse, Ahmad Sajadieh, Helena Dominguez

Summary: This study aims to investigate the effectiveness of IAA closure during open-heart surgery in preventing thromboembolisms in patients with atrial fibrillation. The randomized multicenter trial includes patients from Denmark, Spain, and Sweden and is likely to influence the use of left atrial appendage closure in open-heart surgery.

AMERICAN HEART JOURNAL (2023)

Article Pharmacology & Pharmacy

Predicting successful biologics tapering in patients with inflammatory arthritis: Secondary analyses based on the BIOlogical Dose OPTimisation (BIODOPT) trial

Line Uhrenholt, Kirsten Duch, Robin Christensen, Lene Dreyer, Ellen-Margrethe Hauge, Annette Schlemmer, Peter C. Taylor, Salome Kristensen

Summary: This study aimed to evaluate predictors for successful biologic tapering among patients with inflammatory arthritis. The results showed that the tapering group was the only significant independent predictor for successful tapering, while SF-36 MCS may also be of importance. The study concluded that successful tapering is achievable for patients who are interested in reducing their biological therapy, and no other significant predictors were identified.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Endocrinology & Metabolism

Effects of different doses of exercise and diet-induced weight loss on beta-cell function in type 2 diabetes (DOSE-EX): a randomized clinical trial

Grit E. Legaard, Mark P. P. Lyngbaek, Thomas P. Almdal, Kristian Karstoft, Sebastian L. Bennetsen, Camilla S. Feineis, Nina S. Nielsen, Cody G. Durrer, Benedikte Liebetrau, Ulrikke Nystrup, Martin Ostergaard, Katja Thomsen, Beckey Trinh, Thomas P. J. Solomon, Gerrit Van Hall, Jan Christian Brond, Jens J. Holst, Bolette Hartmann, Robin Christensen, Bente K. Pedersen, Mathias Ried-Larsen

Summary: A randomized clinical trial showed that adding exercise to diet-induced weight loss can improve beta-cell function in people with newly diagnosed type 2 diabetes. The study found that exercise volume is important for improving beta-cell function, and there was a dose-dependent relationship between exercise and beta-cell function improvement.

NATURE METABOLISM (2023)

Article Rheumatology

Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial

Anna Dossing, Marius Henriksen, Karen Ellegaard, Sabrina Mai Nielsen, Lisa K. Stamp, Felix C. Mueller, Margreet Kloppenburg, Ida K. Haugen, Geraldine M. McCarthy, Philip G. Conaghan, Louise Ulff-Moller Dahl, Lene Terslev, Roy D. Altman, Fabio Becce, Elisabeth Ginnerup-Nielsen, Lene Jensen, Mikael Boesen, Robin Christensen, Ulla Dal, Henning Bliddal

Summary: This study aimed to investigate the efficacy and safety of colchicine compared to placebo in the treatment of hand osteoarthritis. The results showed that treatment with colchicine did not effectively relieve finger pain and was associated with more adverse events.

LANCET RHEUMATOLOGY (2023)

Article Clinical Neurology

Effect modification of an effective transdiagnostic cognitive behavioral psychotherapy in youths with common mental health problems: Secondary analyses of the randomized mind-my-mind trial

Martin Koster Rimvall, Ditte Vassard, Sabrina Mai Nielsen, Rasmus Trap Wolf, Kerstin Jessica Plessen, Niels Bilenberg, Per Hove Thomsen, Mikael Thastum, Simon-Peter Neumer, Louise Berg Puggaard, Mette Maria Agner Pedersen, Anne Katrine Pagsberg, Wendy K. Silverman, Christoph U. Correll, Robin Christensen, Pia Jeppesen

Summary: The study found that Mind My Mind (MMM) cognitive behavioral therapy is effective in treating common emotional and behavioral mental health problems in youth, but not all individuals respond satisfactorily to treatment. The analysis revealed that youths with any mental disorder at baseline, comorbidity, and longer duration of untreated mental health problems showed superior treatment benefits. This highlights the importance of community-based programs like MMM for youth with substantial mental health problems.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2023)

暂无数据